In previous studies, our group demonstrated disease-promoting properties for the Jumonji-domain histone demethylase (JHDM) KDM3A in Ewing sarcoma [19–21], as well as pre-clinical efficacy of a pan-JHDM inhibitor in this disease [22]. The gene discussed is KDM3A; the disease is Ewing sarcoma.